Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/LABS stock hub

TSX/LABS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TSX/LABSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
36.1M
Toronto Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TSX/LABS
In the news

Latest news · TSX/LABS

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROE-20.9
P25 -121.5P50 -40.9P75 0.5
ROIC-28
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TSX/LABS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
175
Groups with data
11
Currency
CAD
Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Canada
Country code
CA
Employees
127
Employees Change
-34%
Employees Change Percent
-21.12
Enterprise value
CAD 24.9M
Exchange
Toronto Stock Exchange
Financial currency
CAD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CA58504D1006
Last refreshed
2026-05-10
Market cap
CAD 36.1M
Price
CAD 0.09
Price currency
CAD
Rev Per Employee
355,307.09x
Sector
Healthcare
Sic
2834
Symbol
tsx/LABS
Website
https://www.medipharmlabs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-22.89%
EV Earnings
-3.02x
EV/FCF
-4.45x
EV/Sales
0.55x
FCF yield
-15.52%
P/B ratio
1.01x
P/S ratio
0.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-16%
EBITDA Margin
-12.4%
Gross margin
30.72%
Gross Profit
CAD 13.9M
Gross Profit Growth
9.24%
Gross Profit Growth Q
35.53%
Net Income
CAD -8.3M
Net Income Growth Years
5%
Pretax Margin
-18.32%
Profit Margin
-18.32%
Profit Per Employee
CAD -65,094
ROA
-9.07
Roa5y
-16.32
ROCE
-20.16
ROE
-20.93
Roe5y
-35.62
ROIC
-27.96
Roic5y
-47.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr3y
2.04%
Cagr5y
-28.03%
EPS Growth Quarters
2
EPS Growth Years
5
Revenue Growth
7.54x
Revenue Growth Q
-8.14x
Revenue Growth Years
4x
Revenue Growth3 Y
26.83x
Revenue Growth5 Y
4.61x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
CAD 0.91
Assets
CAD 45.7M
Cash
CAD 11.4M
Current Assets
CAD 27.5M
Current Liabilities
CAD 9.9M
Debt
CAD 201,000
Debt Equity
CAD 0.01
Debt FCF
CAD -0.04
Equity
CAD 35.8M
Interest Coverage
-114.6
Liabilities
CAD 9.9M
Long Term Assets
CAD 18.3M
Long Term Liabilities
CAD 0
Net Cash
CAD 11.2M
Net Cash By Market Cap
CAD 30.92
Net Cash Growth
-2.79%
Net Debt Equity
CAD -0.31
Tangible Book Value
CAD 35.1M
Tangible Book Value Per Share
CAD 0.08
WACC
9.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.77
Inventory Turnover
3.81
Net Working Capital
CAD 6.4M
Quick ratio
1.9
Working Capital
CAD 17.5M
Working Capital Turnover
CAD 2.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-2.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
200-day SMA
0.07
3Y total return
6.25%
50-day SMA
0.07
50-day SMA vs 200-day SMA
50under200
5Y total return
-80.68%
All Time High
7.39
All Time High Change
-98.85%
All Time High Date
2019-05-14
All Time Low
0.06
All Time Low Change
54.55%
All Time Low Date
2023-06-27
ATR
0.01
Beta
0.96
Beta1y
0.79
Beta2y
0.96
Ch YTD
30.77
High
0.09
High52
0.11
High52 Date
2025-05-14
High52ch
-22.73%
Low
0.09
Low52
0.06
Low52 Date
2026-04-22
Low52ch
41.67%
Ma50ch
20.4%
Price vs 200-day SMA
20.06%
RSI
61.46
RSI Monthly
48.48
RSI Weekly
62.95
Sharpe ratio
0.38x
Sortino ratio
0.67
Total Return
-2.53%
Tr YTD
30.77
Tr1m
30.77%
Tr1w
-5.56%
Tr3m
21.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
CAD -7.2M
Operating margin
-16

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
385,939,418%
Net Borrowing
-192,000
Shares Insiders
9.16%
Shares Institutions
0%
Shares Out
424,864,269
Shares Qo Q
0.23%
Shares Yo Y
2.53%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
CAD -6.9M
Average Volume
536,685.4x
Bv Per Share
0.08
CAPEX
CAD -100,000
Ch1m
30.77
Ch1w
-5.56
Ch3m
21.43
Ch3y
6.25
Ch5y
-80.68
Ch6m
21.43
Change
-5.56%
Change From Open
0
Close
0.09
Days Gap
-5.56
Depreciation Amortization
1,625,000
Dollar Volume
2,889
Earnings Date
2026-05-13
EBIT
CAD -7.2M
EBITDA
CAD -5.6M
EPS
CAD -0.02
F Score
3
FCF
CAD -5.6M
FCF EV Yield
-22.46x
FCF Per Share
CAD -0.01
Financing CF
-18,000
Fiscal Year End
December
Founded
2,015
Investing CF
4,620,000
Is Primary Listing
1
Last Earnings Date
2026-03-30
Last Report Date
2025-12-31
Ma150
0.07
Ma150ch
21.08%
Ma20
0.08
Ma20ch
11.55%
Net CF
-884,000
Next Earnings Date
2026-05-13
Open
0.09
Position In Range
0
Ppne
17,596,000
Price Date
2026-05-08
Ptbv Ratio
1.03
Relative Volume
0.06x
Revenue
45,124,000x
SBC By Revenue
2.98x
Share Based Comp
1,344,000
Tr6m
21.43%
Volume
33,988
Z Score
-2.37
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TSX/LABS pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/LABS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
n/a
S&P 500 1Y: n/a
3Y total return
+6.3%
S&P 500 3Y: n/a
5Y total return
-80.7%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TSX/LABS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.0%
Share of float held by funds and institutions
Insider ownership
+9.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+2.5%
Negative means the company is buying back shares.
Technical

TSX/LABS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
61.5
Neutral momentum band
Price vs 200-day MA
+20.1%
50/200-day relationship not available
Beta (5Y)
0.96
Moves roughly with the market
Sharpe ratio
0.38
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TSX/LABS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/LABS stock rating?

tsx/LABS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/LABS analysis?

The full report lives at /stocks/tsx/LABS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/LABS?

The latest report frames tsx/LABS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/LABS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.